Chi Chiu Mok
chief of Rheumatology, Department of Medicine - Tuen Mun Hospital
Chi-Chiu Mok is currently the chief of the Division of Rheumatology, Department of Medicine, Tuen Mun Hospital, Hong Kong. He is a consultant physician and honorary teaching professor of the Chinese University of Hong Kong. Dr. Mok is the convener of the rheumatology service development group in the Hospital Authority of Hong Kong. In addition, Dr. Mok serves as the program director of the Rheumatology / Immunology accreditation board of the Hong Kong College of Physicians.
An active researcher, Dr. Mok is the first author of more than 200 papers in a number of medical and Rheumatology journals that include the Annals of the Rheumatic Diseases, Nature Review Rheumatology, Arthritis and Rheumatology, Rheumatology (Oxford), and Arthritis Care & Research. His research interests include systemic lupus erythematosus, particularly lupus nephritis, and glucocorticoid induced osteoporosis. Dr. Mok is also the principal investigator of more than 10 phase II/III global trials investigating the safety and efficacy of novel biological agents in various rheumatic diseases.
Dr. Mok is currently the senior associate editor of the International Journal of Rheumatic Diseases and an editorial member of the Journal of Rheumatology, Current Rheumatology Review, Open Orthopedic Journal and Immunology and Immunogenetic Insights. In addition, he is an ad-hoc reviewer of more than 60 medical and rheumatology journals.
Dr. Mok is a Past President of the Hong Kong Society of Rheumatology. He is the founder editor of the Hong Kong Bulletin on Rheumatic Diseases, the official publication of the Hong Kong Society of Rheumatology.